Project Grant RF1AG093689
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$3.1M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $147,933 to the University of Florida to conduct a 5-year study investigating the effects of transcranial direct current stimulation (tDCS) on working memory performance and functional connectivity in individuals with mild cognitive impairment (MCI) compared to healthy controls. The study aims to characterize the acute (one-time) application of tDCS with standard fixed dosing on working memory...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $1,167,871 to the Hebrew Rehabilitation Center in Boston, Massachusetts to conduct a randomized controlled trial evaluating the use of home-based transcranial electrical stimulation (tDCS) to improve cognitive and motor function in older adults at risk of developing Alzheimer's disease and related dementias. The study aims to determine if long-term tDCS can induce sustained improvements in...
This Project Grant awarded by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), provides $1,193,500 to the Lovelace Biomedical Research Institute to investigate the mechanisms by which transcranial electrical stimulation (TES) techniques, including transcranial alternating current stimulation (tACS) and transcranial direct current stimulation (tDCS), modulate cerebral microcirculation and endothelial function. The research aims to...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $128,520 to investigate the role of Alzheimer's disease pathology in mild behavioral impairment (MBI). The primary objectives are to: 1) examine the network-level structure-function relations associated with MBI, 2) assess the association between blood-based Alzheimer's biomarkers and MBI symptoms/network-level neurodegeneration, and 3) pilot the use of high-definition transcranial...
This $338,527 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to understand the role of inhibitory interneurons in the pathophysiology of Alzheimer's disease (AD) and related dementias (ADRD). The key objectives are to: 1) Identify disrupted interneuron gene expression in post-mortem AD brain tissue, 2) Characterize inhibitory dysfunction in AD-derived induced interneurons in vitro, and 3) Assess the impact of transplanting healthy...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $128,321.00 to the Regents of the University of Michigan to systematically dissect the retrosplenial cortex (RSG) circuitry in preclinical Alzheimer's disease (AD) mouse models. The key objectives are to: Study biophysical changes in different RSG cell types in two AD mouse models and two age points, in both male and female mice, to generate a cell-type specific physiological map of RSG...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) for $385,612 aims to integrate experimental and computational models to study prefrontal microcircuit changes during healthy aging and Alzheimer's disease progression. The research team at the University of Wyoming will use in vivo calcium imaging, computational simulation modeling, and neural decoding to directly visualize and predict microcircuit changes in the prefrontal cortex. A sub-award of an...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $640,000 to Northeastern University to develop and apply new intravital microscopy techniques. The goal is to gain greater insight into the effects of gamma entrainment, a promising non-pharmacological neuromodulation technique for Alzheimer's disease (AD) and other brain pathologies. The project will focus on characterizing how gamma entrainment influences cerebral energy metabolism and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,929,011 to The Regents of the University of California, San Francisco (UCSF) to conduct a longitudinal, multimodal neuroimaging study investigating the role of neuronal dysfunction and hyperexcitability in the early biological progression of Alzheimer's disease. The study aims to elucidate the earliest manifestations of neural circuit hyperexcitability that predict the accumulation of tau...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $203,278 to Brandeis University from November 2024 to January 2026 to conduct research on the neurobiological mechanisms underlying daily life activity participation in older adults and its relationship to Alzheimer's disease pathology. The project will use a multilevel, multimodal framework including behavioral, psychophysiological, neuroimaging, and naturalistic approaches to understand...